Dividends Inside 
Bristol-Myers Squibb Company
BMY
$65.47 (- $2.14 - 3.17%)
Last updated: 2026-08-21 02:16 UTC
Bristol-Myers Squibb Company trades under ticker BMY on NYSE as a stock. Use this page to review stock price, share price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US1101221083, CUSIP 110122108. Also searched as Bristol-Myers Squibb.
Related researchBMY stock priceBMY share priceBMY dividend historyBMY dividend yieldBristol-Myers Squibb dividend historyBristol-Myers Squibb dividend yield110122108Bristol-Myers Squibb stockBristol-Myers Squibb share price
About the Company
Bristol-Myers Squibb Company is a global biopharmaceutical company focused on discovering, developing, licensing, manufacturing, and commercializing medicines for serious diseases. Bristol-Myers Squibb Company’s portfolio spans oncology, hematology, immunology, cardiovascular disease, and neuroscience, with products that include small-molecule drugs, biologics, and CAR-T cell therapies. The company serves patients and healthcare providers worldwide through branded therapies and specialty medicines used in complex treatment settings. Bristol-Myers Squibb Company also supports ongoing research and development across multiple therapeutic areas, combining scientific expertise with large-scale manufacturing and distribution capabilities. Headquartered in Princeton, New Jersey, and founded in 1933, Bristol-Myers Squibb Company remains a major participant in the global pharmaceutical market, known for advancing treatments aimed at addressing high-need medical conditions.